Author

Dominik Sonanini

German Cancer Research CenterORCID 0000-0002-7085-0161Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:imaging· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Manfred KneillingiD· 2 shared Ainara Barco-TejadaiD· 1 shared André F. MartinsiD· 1 shared Andreas M. SchmidiD· 1 shared Armin Manfred ScholziD· 1 shared Bernd Jürgen PichleriD· 1 shared Bjoern TraenkleiD· 1 shared Cécile GouttefangeasiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Manfred KneillingORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Immune-metabolic PET/MRI uncovers microenvironmental reprogramming under combined immunotherapy and anti-angiogenic therapy

Sixing Li, Marie-Aline C. Neveu, Laura Kuebler, Stefania Pezzana, Ainara Barco-Tejada, Ian WILSON, Irene González-Menéndez, Leticia Quintanilla‐Martínez, Dominik Sonanini, Andreas M. Schmid, Manfred Kneilling, André F. Martins

The paper evaluates ICI-sorafenib combination therapy in TNBC using multimodal imaging and ex vivo analyses, showing tumor growth suppression and TME remodeling.

bioRxiv · Aug 7, 2026 · PreprintCancer Biology

Making the effect visible - OX40 targeting nanobodies for in vivo imaging of activated T cells

Desiree Isabella Frecot, Simone Blaess, Teresa R. Wagner, Philipp D. Kaiser, Bjoern Traenkle, Madeleine Fandrich, Meike Jakobi, Armin Manfred Scholz, Stefan Nueske, Nicole Schneiderhan‐Marra, Cécile Gouttefangeas, Manfred Kneilling, Bernd Jürgen Pichler, Dominik Sonanini, Ulrich Rothbauer

This paper develops nanobodies targeting hOX40 for in vivo imaging of activated T cells, showing they bind specifically and function as imaging probes without affecting T cell viability.

Frontiers in Immunology · Oct 15, 2024Peer-reviewedImmunology